{"path":"Images/Pasted image 20240117133416.png","text":"Hemolytic Reaction: Cardiac instability, bronchospasm, bleeding, dark urine; Non-hemolytic Reaction: fever, rash, pulmonary edema; Anaphylactic Reaction: hypotension, urticaria, bronchospasm START DRUG DOSES & treatments EPINEPHrine BOLUS:10-20 MCG IV 1. Ccallforhelp (1 mgin 100 mL = 10 MCG/mL) INFUSION: 0.01 - 0.1 MCG; it > Ask: “Who will be the crisis manager?” /g /min P Crisis manager designates checklist reader Furosemide 40 mglv 2. Disconnect any blood products infusing Albuterol 2-3 puffs MDI via ETT > Check blood product labels for correct patient name and ABO compatibility 25 mgia nebulizer > Send the blood product(s) back to the blood bank for evaluation DIFFERENTIAL diagnosis 3. Support hemodynamics with EPINEPHrine Araplylsisfrom other causes (CHKLST 02) > Repeat bolus with increasing dose as needed ?ypﬂ;ﬂflor;?(fﬂzdﬁlz Lunginjory (TRAL) j pereenne ransfusion Related Acute Lung Injury > Consider EPINEPHrine infusion T e s aco) 4. Manage bronchospasm Septic Shock _ Other hemolytic anemias (idiopathic, HUS, HELLP) > Fi0,100% > Albuterol or EPINEPHrine 5. Maintain urine output if hemolysis noted > Volume load 20 mL / kg crystalloid. Caution if signs of volume overload. > Consider furosemide or mannitol to goal UOP 1-2 mL / kg / hr 6. Monitor labs > Arterial or venous blood gas, electrolytes > PT,aPTT, fibrinogen, viscoelastography > Direct antiglobulin (Coomb's) test, haptoglobin, LDH, free hemoglobin, tryptase 7. Considerinvasive lines > Arterial line for ongoing hemodynamic instability > Central venous catheter for vasopressors 8. Further treatment > Consider hematology consult and ICU disposition","libVersion":"0.3.2","langs":"eng"}